Structural requirements for biological activity of glucagon-like peptide-I
The following information reflects dosages commonly reported in research literature and anecdotal use
If you decide to check them out, do me a favour and use code Peptide10 for 10% off your order
Cancelled Phase I Trial: A 2015 Phase I study with 42 volunteers was registered, but the results were never published, and no public explanation was provided
Today, it is used in both medical and cosmetic applications due to its ability to repair damaged tissue, reduce inflammation, and stimulate collagen and elastin production
When used as part of a comprehensive recovery protocol, especially post-AAS cycle or during periods of heavy training, BPC-157 may offer protective and reparative effects unmatched by conventional treatments